Results 181 to 190 of about 8,864 (209)

POSC257 Radiopharmaceutical Treatments and HTA: The Case of [177lu]-DOTATATE

Value in Health, 2022
E Garagiola, LB Ferrario, O Bagni, CM Grana, S Lastoria, RE Pellerito, M Salgarello, E Seregni, S Severi, G Storto, A Versari, E Foglia   +11 more
openaire   +1 more source

Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu

Nuclear Medicine and Molecular Imaging, 2022
Buvaneswari Gopal
exaly  

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients

European Journal of Nuclear Medicine and Molecular Imaging, 2022
Katarina Sjögreen Gleisner, Andreas Hallqvist, Johanna Svensson   +2 more
exaly  

177Lu-Dotatate for midgut neuroendocrine tumours

The Lancet Oncology, 2017
openaire   +1 more source

The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts

European Journal of Nuclear Medicine and Molecular Imaging, 2020
Nakul R Raval, Sara Lundsten, Diana Spiegelberg   +2 more
exaly  

Unusual accumulation of 177Lu-DOTATATE at the injection site of a COVID-19 vaccination

Nuklearmedizin - NuclearMedicine, 2022
Christof, Scheer, Michael, Jüptner, Timo, Maier, Ulf, Lützen   +3 more
openaire   +2 more sources

177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: Indigenously Developed Freeze Dried Cold Kit and Biological Response in In-Vitro and In-Vivo Models

Dose-Response, 2021
Syed Ali Raza Naqvi
exaly  

The efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours: a systematic review and meta-analysis

Journal of Cancer Research and Clinical Oncology, 2020
Qi Song, Liang Cai
exaly  

177Lu-DOTATATE in older patients with metastatic neuroendocrine tumours: safety, efficacy and health-related quality of life

European Journal of Nuclear Medicine and Molecular Imaging, 2021
Christos Toumpanakis, Dalvinder Mandair, Martyn Caplin   +2 more
exaly  

Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study

European Journal of Nuclear Medicine and Molecular Imaging, 2022
Rajaventhan Srirajaskanthan, Frédéric Courbon, Beilei He   +2 more
exaly